Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic.
Mayo Clin Proc
; 95(11): 2467-2486, 2020 11.
Article
in English
| MEDLINE | ID: covidwho-735313
ABSTRACT
A higher risk of thrombosis has been described as a prominent feature of coronavirus disease 2019 (COVID-19). This systematic review synthesizes current data on thrombosis risk, prognostic implications, and anticoagulation effects in COVID-19. We included 37 studies from 4070 unique citations. Meta-analysis was performed when feasible. Coagulopathy and thrombotic events were frequent among patients with COVID-19 and further increased in those with more severe forms of the disease. We also present guidance on the prevention and management of thrombosis from a multidisciplinary panel of specialists from Mayo Clinic. The current certainty of evidence is generally very low and continues to evolve.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Thrombosis
/
Practice Guidelines as Topic
/
SARS-CoV-2
/
COVID-19 Drug Treatment
/
Anticoagulants
Type of study:
Observational study
/
Prognostic study
/
Reviews
/
Systematic review/Meta Analysis
Topics:
Long Covid
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
Mayo Clin Proc
Year:
2020
Document Type:
Article
Affiliation country:
J.mayocp.2020.08.030
Similar
MEDLINE
...
LILACS
LIS